SQUAWK/NEWS
Theme
Menu
Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

3 results loaded, newest first. End of these results.

News 2026-06-25 11:04 UTC

Kymera Completes Enrollment

Kymera Therapeutics completes enrollment in global BROADEN2 Phase 2b trial of KT-621 for atopic dermatitis treatment

News 2026-06-25 11:00 UTC

KYMR Completes Enrollment

Kymera Therapeutics completes enrollment in the Phase 2b BROADEN2 trial of KT-621 in atopic dermatitis with topline data expected by year-end 2026